Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 34,565 | 20,617 | 20,917 | 59,225 | 55,147 |
| Cost of Goods | 6,462 | 5,238 | 1,399 | 2,563 | 2,243 |
| Gross Profit | 28,103 | 15,379 | 19,518 | 56,662 | 52,904 |
| Operating Expenses | 35,240 | 41,369 | 36,549 | 248,210 | 63,280 |
| Operating Income | -6,675 | -25,752 | -16,632 | -190,985 | -10,133 |
| Interest Expense | 3,050 | 1,604 | 8,674 | 13,121 | 13,872 |
| Other Income | 253 | -16,615 | 68,584 | 6,561 | 25,621 |
| Pre-tax Income | -9,472 | -43,971 | 43,278 | -197,545 | 1,616 |
| Income Tax | 1,050 | -9,472 | 2,048 | -4,919 | -1,715 |
| Net Income Continuous | -10,522 | -34,499 | 41,230 | -192,626 | 3,331 |
| Net Income | $-10,522 | $-34,499 | $41,230 | $-192,626 | $3,331 |
| EPS Basic Total Ops | -0.35 | -1.40 | 2.04 | -10.76 | 0.20 |
| EPS Basic Continuous Ops | -0.35 | -1.40 | 2.03 | -10.73 | 0.18 |
| EPS Diluted Total Ops | -0.35 | -1.40 | 2.04 | -10.76 | 0.20 |
| EPS Diluted Continuous Ops | -0.35 | -1.40 | 2.03 | -10.73 | 0.18 |
| EBITDA(a) | $-423 | $-20,377 | $-3,177 | $-159,590 | $21,459 |